Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0023868554
Wed, 23.11.2022
Implenia AG
Implenia AG
/ Key word(s): Alliance
Implenia signs cooperation agreement with Deutsche Asset One and Union Investment for project developments in German residential real estate market
23.11.2022 / 07:00 CET/CEST
Agreement brings together Implenia’s specialist expertise with the partner companies’ portfolio and asset management sk [ … ]
Wed, 16.11.2022
Implenia AG
Implenia AG
/ Key word(s): Incoming Orders
Implenia wins further large, complex new-build and modernisation projects in Switzerland
16.11.2022 / 07:00 CET/CEST
Office and commercial property in Lucerne | New building for Lucerne Cantonal Hospital | Several modernisation projects in German and French-speaking regions of Switzerlan [ … ]
Wed, 16.11.2022
Implenia AG
Implenia AG
/ Key word(s): Incoming Orders
Implenia wins further large, complex new-build and modernisation projects in Switzerland
16.11.2022 / 07:00 CET/CEST
Office and commercial property in Lucerne | New building for Lucerne Cantonal Hospital | Several modernisation projects in German and French-speaking regions of Switzerlan [ … ]
Fri, 11.11.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
Existing CHF 650 million loan agreement with Swiss banking syndicate extended until December 2027.
Glattpark (Opfikon), 11 November 2022 – Implenia has extended and signed its CHF 650 million unsecured syndicated loan, which was originally set to mature in December 2023. The terms and greater flexibility o [ … ]
Fri, 11.11.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
Existing CHF 650 million loan agreement with Swiss banking syndicate extended until December 2027.
Glattpark (Opfikon), 11 November 2022 – Implenia has extended and signed its CHF 650 million unsecured syndicated loan, which was originally set to mature in December 2023. The terms and greater flexibility o [ … ]
Tue, 01.11.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
‘Fit for Growth’ phase within Implenia’s strategic priorities to further strengthen competitive position
Divisions contribute to focus areas: improve existing business, grow existing business, develop new business, selective acquisitions
Group financial targets: emphasis on profitability, strength [ … ]
Tue, 01.11.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
‘Fit for Growth’ phase within Implenia’s strategic priorities to further strengthen competitive position
Divisions contribute to focus areas: improve existing business, grow existing business, develop new business, selective acquisitions
Group financial targets: emphasis on profitability, strength [ … ]
Tue, 18.10.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
New laboratory for University of Basel’s Department of Biomedicine | Latest project in research and health sector | Contract worth over CHF 250 million | BIM and Lean Construction used for planning and execution
Glattpark (Opfikon), 18 October 2022 – The University of Basel has contracted Implenia Divisio [ … ]
Tue, 18.10.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
New laboratory for University of Basel’s Department of Biomedicine | Latest project in research and health sector | Contract worth over CHF 250 million | BIM and Lean Construction used for planning and execution
Glattpark (Opfikon), 18 October 2022 – The University of Basel has contracted Implenia Divisio [ … ]
Wed, 17.08.2022
Implenia AG
Ad hoc announcement pursuant to Art. 53 LR
Implenia increased EBIT significantly to CHF 95.1 million
Equity improved by CHF 106 million and equity ratio substantially increased to 16.0%, stronger free cash flow than in the same period of previous year
Continued positive order intake, with further improved quality
Transformation complet [ … ]